What's in Skingenix, Inc.'s pipeline?

Skingenix, Inc. has 4 drugs in our index: 1 marketed, 0 filed, 1 in Phase 3, 2 in Phase 2, 0 in Phase 1.

Which companies overlap with Skingenix, Inc.'s portfolio?

Top competitors by shared drug class: Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia, Chiesi Farmaceutici S.p.A., Oneness Biotech Co., Ltd., Suez Canal University, The Metis Foundation.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/skingenix-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Skingenix, Inc. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Skingenix, Inc. pipeline: 1 marketed, 0 filed, 1 Phase 3, 2 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 1 Phase 3 2 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
MEBO Wound Ointment	MEBO Wound Ointment	marketed	Topical wound healing agent		Dermatology / Wound Care
MEBO Wound Ointment (MEBO)	MEBO Wound Ointment (MEBO)	phase 3	Topical wound healing agent		Dermatology / Wound Care

Therapeutic area mix

Dermatology / Wound Care · 2

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia · 1 shared drug class
Chiesi Farmaceutici S.p.A. · 1 shared drug class
Oneness Biotech Co., Ltd. · 1 shared drug class
Suez Canal University · 1 shared drug class
The Metis Foundation · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Skingenix, Inc.:

Cite this brief

Drug Landscape (2026). Skingenix, Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/skingenix-inc. Accessed 2026-05-16.